Genmab A/S
GMAB
$21.78
$0.110.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 195.00M | 549.50M | 186.55M | 203.16M | 192.00M |
| Total Depreciation and Amortization | 16.00M | 16.44M | 16.50M | 23.66M | 13.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.00M | -186.36M | 173.73M | 90.90M | -47.00M |
| Change in Net Operating Assets | 75.00M | 8.00M | -77.22M | -99.42M | 61.00M |
| Cash from Operations | 287.00M | 387.58M | 299.58M | 218.31M | 219.00M |
| Capital Expenditure | -12.00M | -13.43M | -5.60M | -3.90M | -4.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -1.77B | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.00M | 25.15M | 38.61M | 505.16M | -206.00M |
| Cash from Investing | -43.00M | 11.72M | 33.01M | -1.27B | -210.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00M | 0.00 | -17.00M | -19.00M | -3.00M |
| Issuance of Common Stock | 1.00M | 11.00M | 43.00M | 16.00M | 9.00M |
| Repurchase of Common Stock | -12.00M | -8.00M | -302.00M | -3.05B | -91.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.00M | 428.70K | -40.67M | -440.23M | -85.00M |
| Foreign Exchange rate Adjustments | 8.00M | 102.76M | 4.42M | -4.18M | -1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.00M | 502.49M | 296.34M | -1.49B | -77.00M |